Ruxandra Draghia-Akli - 11 Nov 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Section 16
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
11 Nov 2025
Net transactions value
-$44,755
Form type
4
Filing time
13 Nov 2025, 17:23:25 UTC
Previous filing
05 Mar 2025
Next filing
09 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Draghia-Akli Ruxandra Section 16 21 FIRSTFIELD ROAD, GAITHERSBURG /s/ Mark J. Casey, Attorney-in-Fact 13 Nov 2025 0002041719

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +14,257 $0.000000 14,257 11 Nov 2025 Direct
transaction NVAX Common Stock Tax liability $44,755 -6,048 -42% $7.40 8,209 11 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Disposed to Issuer $0 -14,257 -33% $0.000000 28,513 11 Nov 2025 Common Stock 14,257 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F2 One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.